CH618414A5 - - Google Patents
Download PDFInfo
- Publication number
- CH618414A5 CH618414A5 CH1588575A CH1588575A CH618414A5 CH 618414 A5 CH618414 A5 CH 618414A5 CH 1588575 A CH1588575 A CH 1588575A CH 1588575 A CH1588575 A CH 1588575A CH 618414 A5 CH618414 A5 CH 618414A5
- Authority
- CH
- Switzerland
- Prior art keywords
- radical
- formula
- compounds
- carbon atoms
- mixture
- Prior art date
Links
- -1 naphthyl radical Chemical class 0.000 claims description 59
- 150000001875 compounds Chemical class 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 150000003839 salts Chemical class 0.000 claims description 25
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 125000005843 halogen group Chemical group 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical compound O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 4
- 239000012442 inert solvent Substances 0.000 claims description 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- 238000001640 fractional crystallisation Methods 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 150000003254 radicals Chemical class 0.000 claims description 2
- 229960002179 ephedrine Drugs 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 84
- 239000000203 mixture Substances 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 239000003208 petroleum Substances 0.000 description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 239000003921 oil Substances 0.000 description 15
- 239000002253 acid Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 239000007787 solid Substances 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910000104 sodium hydride Inorganic materials 0.000 description 7
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- OLCRCPCKHIILMR-UHFFFAOYSA-N ethyl 3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanoate Chemical compound CCOC(=O)C(O)(C(F)(F)F)C(F)(F)F OLCRCPCKHIILMR-UHFFFAOYSA-N 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- NFCOSRCEYMBQCJ-UHFFFAOYSA-N 1-chloro-4-[4-(chloromethyl)phenyl]benzene Chemical compound C1=CC(CCl)=CC=C1C1=CC=C(Cl)C=C1 NFCOSRCEYMBQCJ-UHFFFAOYSA-N 0.000 description 5
- NKNWDMQCOPTACU-UHFFFAOYSA-N 2-chloro-6-(chloromethyl)naphthalene Chemical compound C1=C(Cl)C=CC2=CC(CCl)=CC=C21 NKNWDMQCOPTACU-UHFFFAOYSA-N 0.000 description 5
- XBLVHTDFJBKJLG-UHFFFAOYSA-N Ethyl nicotinate Chemical compound CCOC(=O)C1=CC=CN=C1 XBLVHTDFJBKJLG-UHFFFAOYSA-N 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- MBYRLQSEGUSDFE-UHFFFAOYSA-N 2-[[4-(4-chlorophenyl)phenyl]methoxy]-3,3,3-trifluoro-2-(trifluoromethyl)propanoic acid Chemical compound C1=CC(COC(C(=O)O)(C(F)(F)F)C(F)(F)F)=CC=C1C1=CC=C(Cl)C=C1 MBYRLQSEGUSDFE-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 4
- 230000002456 anti-arthritic effect Effects 0.000 description 4
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000012258 stirred mixture Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- JYLGKVDVIPITQM-UHFFFAOYSA-N 2-(chloromethyl)-6-methoxynaphthalene Chemical compound C1=C(CCl)C=CC2=CC(OC)=CC=C21 JYLGKVDVIPITQM-UHFFFAOYSA-N 0.000 description 3
- WUMAGBFCMDODFV-UHFFFAOYSA-N 2-[[4-(4-chlorophenyl)phenyl]methoxy]-3,3,3-trifluoro-2-methylpropanoic acid Chemical compound C1=CC(COC(C)(C(O)=O)C(F)(F)F)=CC=C1C1=CC=C(Cl)C=C1 WUMAGBFCMDODFV-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- JQIVIJNGOXXHPV-UHFFFAOYSA-N methyl 3,3,3-trifluoro-2-hydroxy-2-methylpropanoate Chemical compound COC(=O)C(C)(O)C(F)(F)F JQIVIJNGOXXHPV-UHFFFAOYSA-N 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- KWGRBVOPPLSCSI-PSASIEDQSA-N (1s,2r)-2-(methylamino)-1-phenylpropan-1-ol Chemical compound CN[C@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-PSASIEDQSA-N 0.000 description 2
- BJGJYPRQYKBIRZ-UHFFFAOYSA-N (6-chloronaphthalen-2-yl)methanol Chemical compound C1=C(Cl)C=CC2=CC(CO)=CC=C21 BJGJYPRQYKBIRZ-UHFFFAOYSA-N 0.000 description 2
- XMWGTKZEDLCVIG-UHFFFAOYSA-N 1-(chloromethyl)naphthalene Chemical compound C1=CC=C2C(CCl)=CC=CC2=C1 XMWGTKZEDLCVIG-UHFFFAOYSA-N 0.000 description 2
- JQZAEUFPPSRDOP-UHFFFAOYSA-N 1-chloro-4-(chloromethyl)benzene Chemical compound ClCC1=CC=C(Cl)C=C1 JQZAEUFPPSRDOP-UHFFFAOYSA-N 0.000 description 2
- MPCHQYWZAVTABQ-UHFFFAOYSA-N 2-(chloromethyl)naphthalene Chemical compound C1=CC=CC2=CC(CCl)=CC=C21 MPCHQYWZAVTABQ-UHFFFAOYSA-N 0.000 description 2
- SRISHMVSUHENAI-UHFFFAOYSA-N 6-chloronaphthalene-2-carboxylic acid Chemical compound C1=C(Cl)C=CC2=CC(C(=O)O)=CC=C21 SRISHMVSUHENAI-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 150000004645 aluminates Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- GEAXLHPORCRESC-UHFFFAOYSA-N chlorocyclohexatriene Chemical compound ClC1=CC=C=C[CH]1 GEAXLHPORCRESC-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 150000002440 hydroxy compounds Chemical class 0.000 description 2
- 230000000055 hyoplipidemic effect Effects 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- FYEHTBMLYNKRSY-UHFFFAOYSA-N methyl 6-chloronaphthalene-2-carboxylate Chemical compound C1=C(Cl)C=CC2=CC(C(=O)OC)=CC=C21 FYEHTBMLYNKRSY-UHFFFAOYSA-N 0.000 description 2
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000004533 oil dispersion Substances 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- VOLGAXAGEUPBDM-UHFFFAOYSA-N $l^{1}-oxidanylethane Chemical compound CC[O] VOLGAXAGEUPBDM-UHFFFAOYSA-N 0.000 description 1
- YKZCYRHZTSJCAO-UHFFFAOYSA-N (6-methoxynaphthalen-2-yl)methanol Chemical compound C1=C(CO)C=CC2=CC(OC)=CC=C21 YKZCYRHZTSJCAO-UHFFFAOYSA-N 0.000 description 1
- QOOQLKSEGVNYLA-UHFFFAOYSA-N 1-$l^{1}-oxidanylbutane Chemical compound CCCC[O] QOOQLKSEGVNYLA-UHFFFAOYSA-N 0.000 description 1
- HCZZBHVHIMDUSH-UHFFFAOYSA-N 1-(6-chloronaphthalen-2-yl)ethanone Chemical compound C1=C(Cl)C=CC2=CC(C(=O)C)=CC=C21 HCZZBHVHIMDUSH-UHFFFAOYSA-N 0.000 description 1
- HLQZCRVEEQKNMS-UHFFFAOYSA-N 1-(chloromethyl)-4-phenylbenzene Chemical compound C1=CC(CCl)=CC=C1C1=CC=CC=C1 HLQZCRVEEQKNMS-UHFFFAOYSA-N 0.000 description 1
- HQBGPWSWECNSAI-UHFFFAOYSA-N 1-chloro-4-[4-(chloromethoxy)phenyl]benzene Chemical compound C1=CC(OCCl)=CC=C1C1=CC=C(Cl)C=C1 HQBGPWSWECNSAI-UHFFFAOYSA-N 0.000 description 1
- WGUXTQDCAZNJIF-UHFFFAOYSA-N 1-methyl-3,5-bis(trifluoromethyl)benzene Chemical compound CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 WGUXTQDCAZNJIF-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- UHPVNTVSNXHMPW-UHFFFAOYSA-N 2-[(4-chloronaphthalen-1-yl)methoxy]-3,3,3-trifluoro-2-methylpropanoic acid Chemical compound C1=CC=C2C(COC(C)(C(O)=O)C(F)(F)F)=CC=C(Cl)C2=C1 UHPVNTVSNXHMPW-UHFFFAOYSA-N 0.000 description 1
- KRAQQGMBUFZWSR-UHFFFAOYSA-N 2-[(6-chloronaphthalen-2-yl)methoxy]-3,3,3-trifluoro-2-methylpropanoic acid Chemical compound C1=C(Cl)C=CC2=CC(COC(C)(C(O)=O)C(F)(F)F)=CC=C21 KRAQQGMBUFZWSR-UHFFFAOYSA-N 0.000 description 1
- JYMSVNHODSJOPS-UHFFFAOYSA-N 2-aminoethyl pyridine-3-carboxylate Chemical compound NCCOC(=O)C1=CC=CN=C1 JYMSVNHODSJOPS-UHFFFAOYSA-N 0.000 description 1
- ILPUOPPYSQEBNJ-UHFFFAOYSA-N 2-methyl-2-phenoxypropanoic acid Chemical class OC(=O)C(C)(C)OC1=CC=CC=C1 ILPUOPPYSQEBNJ-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- JQMQLVGEPLJNSI-UHFFFAOYSA-N 3,3,3-trifluoro-2-(naphthalen-2-ylmethoxy)-2-(trifluoromethyl)propanoic acid Chemical compound C1=CC=CC2=CC(COC(C(=O)O)(C(F)(F)F)C(F)(F)F)=CC=C21 JQMQLVGEPLJNSI-UHFFFAOYSA-N 0.000 description 1
- CMQUGOHGJUTDGZ-UHFFFAOYSA-N 3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanoic acid Chemical compound OC(=O)C(O)(C(F)(F)F)C(F)(F)F CMQUGOHGJUTDGZ-UHFFFAOYSA-N 0.000 description 1
- JAINPVBSPNFKCW-UHFFFAOYSA-N 3,3,3-trifluoro-2-methyl-2-(naphthalen-1-ylmethoxy)propanoic acid Chemical compound C1=CC=C2C(COC(C)(C(O)=O)C(F)(F)F)=CC=CC2=C1 JAINPVBSPNFKCW-UHFFFAOYSA-N 0.000 description 1
- DQOGDQIDOONUSK-UHFFFAOYSA-N 3,3,3-trifluoro-2-methylpropanoic acid Chemical compound OC(=O)C(C)C(F)(F)F DQOGDQIDOONUSK-UHFFFAOYSA-N 0.000 description 1
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 1
- ICVFJPSNAUMFCW-UHFFFAOYSA-N 4-Chloro-4'-biphenylol Chemical compound C1=CC(O)=CC=C1C1=CC=C(Cl)C=C1 ICVFJPSNAUMFCW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- UNQXOHYYXJQCIA-UHFFFAOYSA-N [O]c1ccc(Cl)cc1 Chemical compound [O]c1ccc(Cl)cc1 UNQXOHYYXJQCIA-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- JAZHBIYLMGAOGW-UHFFFAOYSA-N ethyl 2-[(6-chloronaphthalen-2-yl)methoxy]-3,3,3-trifluoro-2-(trifluoromethyl)propanoate Chemical compound C1=C(Cl)C=CC2=CC(COC(C(=O)OCC)(C(F)(F)F)C(F)(F)F)=CC=C21 JAZHBIYLMGAOGW-UHFFFAOYSA-N 0.000 description 1
- QCAZFLIEKCGFAV-UHFFFAOYSA-N ethyl 2-[[4-(4-chlorophenyl)phenyl]methoxy]-3,3,3-trifluoro-2-(trifluoromethyl)propanoate Chemical compound C1=CC(COC(C(=O)OCC)(C(F)(F)F)C(F)(F)F)=CC=C1C1=CC=C(Cl)C=C1 QCAZFLIEKCGFAV-UHFFFAOYSA-N 0.000 description 1
- QSNYQNIDWMATAE-UHFFFAOYSA-N ethyl 3,3,3-trifluoro-2-(naphthalen-2-ylmethoxy)-2-(trifluoromethyl)propanoate Chemical compound C1=CC=CC2=CC(COC(C(=O)OCC)(C(F)(F)F)C(F)(F)F)=CC=C21 QSNYQNIDWMATAE-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- NSVRFFIHZUEVTN-UHFFFAOYSA-N methyl 2-[(4-chloronaphthalen-1-yl)methoxy]-3,3,3-trifluoro-2-methylpropanoate Chemical compound C1=CC=C2C(COC(C)(C(=O)OC)C(F)(F)F)=CC=C(Cl)C2=C1 NSVRFFIHZUEVTN-UHFFFAOYSA-N 0.000 description 1
- GPEOIQXHEJFMLW-UHFFFAOYSA-N methyl 2-[(4-chlorophenyl)methoxy]-3,3,3-trifluoro-2-methylpropanoate Chemical compound COC(=O)C(C)(C(F)(F)F)OCC1=CC=C(Cl)C=C1 GPEOIQXHEJFMLW-UHFFFAOYSA-N 0.000 description 1
- NPKWTHWJEUUOED-UHFFFAOYSA-N methyl 2-[[4-(4-chlorophenyl)phenyl]methoxy]-3,3,3-trifluoro-2-methylpropanoate Chemical compound C1=CC(COC(C)(C(=O)OC)C(F)(F)F)=CC=C1C1=CC=C(Cl)C=C1 NPKWTHWJEUUOED-UHFFFAOYSA-N 0.000 description 1
- SEWPIJBPLUWMPM-UHFFFAOYSA-N methyl 3,3,3-trifluoro-2-[(6-methoxynaphthalen-2-yl)methoxy]-2-methylpropanoate Chemical compound C1=C(OC)C=CC2=CC(COC(C)(C(=O)OC)C(F)(F)F)=CC=C21 SEWPIJBPLUWMPM-UHFFFAOYSA-N 0.000 description 1
- URIXEVPUSVYOGS-UHFFFAOYSA-N methyl 3,3,3-trifluoro-2-methyl-2-(naphthalen-1-ylmethoxy)propanoate Chemical compound C1=CC=C2C(COC(C)(C(=O)OC)C(F)(F)F)=CC=CC2=C1 URIXEVPUSVYOGS-UHFFFAOYSA-N 0.000 description 1
- UULUTLBHTPGULX-UHFFFAOYSA-N methyl 3,3,3-trifluoro-2-methyl-2-(naphthalen-2-ylmethoxy)propanoate Chemical compound C1=CC=CC2=CC(COC(C)(C(=O)OC)C(F)(F)F)=CC=C21 UULUTLBHTPGULX-UHFFFAOYSA-N 0.000 description 1
- ZLVPRNFYGCBLDS-UHFFFAOYSA-N methyl 6-methoxynaphthalene-2-carboxylate Chemical compound C1=C(OC)C=CC2=CC(C(=O)OC)=CC=C21 ZLVPRNFYGCBLDS-UHFFFAOYSA-N 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- JVWOCHRRAWHKLT-UHFFFAOYSA-N nicametate Chemical compound CCN(CC)CCOC(=O)C1=CC=CN=C1 JVWOCHRRAWHKLT-UHFFFAOYSA-N 0.000 description 1
- 229960004738 nicotinyl alcohol Drugs 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- JDIYNIZGDAGPPS-UHFFFAOYSA-N sodium;3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanenitrile Chemical compound [Na].N#CC(O)(C(F)(F)F)C(F)(F)F JDIYNIZGDAGPPS-UHFFFAOYSA-N 0.000 description 1
- HKPHUICWPSKEMR-UHFFFAOYSA-M sodium;chloromethanesulfonate Chemical compound [Na+].[O-]S(=O)(=O)CCl HKPHUICWPSKEMR-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
- C07C51/29—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation with halogen-containing compounds which may be formed in situ
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/115—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/72—Polycyclic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/12—Radicals substituted by halogen atoms or nitro or nitroso radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB52829/74A GB1499508A (en) | 1974-12-06 | 1974-12-06 | 3,3,3-trifluoropropionic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH618414A5 true CH618414A5 (fi) | 1980-07-31 |
Family
ID=10465488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1588575A CH618414A5 (fi) | 1974-12-06 | 1975-12-05 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4055595A (fi) |
| JP (1) | JPS51125227A (fi) |
| AR (1) | AR213278A1 (fi) |
| AT (1) | AT347432B (fi) |
| BE (1) | BE836353A (fi) |
| CA (1) | CA1064498A (fi) |
| CH (1) | CH618414A5 (fi) |
| CS (1) | CS191948B2 (fi) |
| DD (1) | DD122963A5 (fi) |
| DE (1) | DE2554882A1 (fi) |
| DK (1) | DK546575A (fi) |
| ES (3) | ES443237A1 (fi) |
| FI (1) | FI753393A (fi) |
| FR (1) | FR2293196A1 (fi) |
| GB (1) | GB1499508A (fi) |
| HU (1) | HU170016B (fi) |
| IE (1) | IE42454B1 (fi) |
| IL (1) | IL48477A (fi) |
| LU (1) | LU73936A1 (fi) |
| NL (1) | NL7514070A (fi) |
| NO (1) | NO753837L (fi) |
| PL (3) | PL102292B1 (fi) |
| SE (1) | SE7513676L (fi) |
| SU (1) | SU764608A3 (fi) |
| ZA (1) | ZA757089B (fi) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU884568A3 (ru) * | 1977-10-07 | 1981-11-23 | Сьянс Юньон Э Ко.,Сосьете Франсэз Де Решерш Медикаль(Фирма) | Способ получени (арилалкил) алкановых кислот |
| FR2460286A1 (fr) * | 1979-06-29 | 1981-01-23 | Rhone Poulenc Agrochimie | Procede de preparation d'acide phenoxy-2 propioniques optiquement actifs |
| EP0026289B1 (en) * | 1979-07-26 | 1982-06-02 | E.I. Du Pont De Nemours And Company | Antihypertensive polyhalohydroxyisopropyl phenylalkanoic and phenylalkenoic acids, amides and esters, pharmaceutical compositions therefrom and intermediates thereto |
| DE3028627A1 (de) * | 1980-07-29 | 1982-03-04 | Basf Ag, 6700 Ludwigshafen | 2-fluoralkancarbonsaeureverbindungen, verfahren zu ihrer herstellung, diese enthaltende herbizide und ihre anwendung |
| DE4327365A1 (de) * | 1993-08-14 | 1995-02-16 | Boehringer Mannheim Gmbh | Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung |
| US6664022B1 (en) | 2000-08-25 | 2003-12-16 | Shipley Company, L.L.C. | Photoacid generators and photoresists comprising same |
| GB0808986D0 (en) | 2008-05-16 | 2008-06-25 | Univ Newcastle | Formation of 18F and 19F fluoroarenes bearing reactive functionalities |
| US7935269B2 (en) * | 2009-05-19 | 2011-05-03 | North American Salt Company | Deicing blend and method of using the same |
| CN115067318B (zh) * | 2022-02-22 | 2023-07-14 | 深圳中检联新药检测有限责任公司 | 一种牙髓间充质干细胞保存液及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3379752A (en) * | 1964-05-20 | 1968-04-23 | Merck & Co Inc | Phenoxy substituted 3-hydroxyalkanoic acids and a method for their preparation |
| US3347910A (en) * | 1964-12-10 | 1967-10-17 | Merck & Co Inc | Cycloaliphatic substituted naphthyloxy-alkanoic acids and a method for their preparation |
| GB1140748A (en) * | 1966-06-23 | 1969-01-22 | Ici Ltd | New carboxylic acid derivatives |
| US3721703A (en) * | 1968-01-11 | 1973-03-20 | Hoechst Ag | Phenoxyalkane-carboxylic acids,salts and esters thereof |
| US3642869A (en) * | 1969-07-30 | 1972-02-15 | Squibb & Sons Inc | 5 8-dihydronaphthyloxy acetic acids |
| US3740437A (en) * | 1970-06-25 | 1973-06-19 | Syntex Corp | Naphthyloxyacetic acids and pharmaceutical compositions and methods thereof |
| DE2223894C3 (de) * | 1972-05-17 | 1981-07-23 | Hoechst Ag, 6000 Frankfurt | Herbizide Mittel auf Basis von Phenoxycarbonsäurederivaten |
-
1974
- 1974-12-06 GB GB52829/74A patent/GB1499508A/en not_active Expired
-
1975
- 1975-11-07 IE IE2434/75A patent/IE42454B1/en unknown
- 1975-11-10 US US05/630,685 patent/US4055595A/en not_active Expired - Lifetime
- 1975-11-11 ZA ZA00757089A patent/ZA757089B/xx unknown
- 1975-11-14 NO NO753837A patent/NO753837L/no unknown
- 1975-11-14 IL IL48477A patent/IL48477A/xx unknown
- 1975-11-27 AR AR261378A patent/AR213278A1/es active
- 1975-12-02 FI FI753393A patent/FI753393A/fi not_active Application Discontinuation
- 1975-12-03 PL PL1975185202A patent/PL102292B1/pl unknown
- 1975-12-03 PL PL1975196814A patent/PL102604B1/pl unknown
- 1975-12-03 DK DK546575A patent/DK546575A/da not_active Application Discontinuation
- 1975-12-03 PL PL1975196815A patent/PL102241B1/pl unknown
- 1975-12-03 NL NL7514070A patent/NL7514070A/xx not_active Application Discontinuation
- 1975-12-04 LU LU73936A patent/LU73936A1/xx unknown
- 1975-12-04 SE SE7513676A patent/SE7513676L/sv not_active Application Discontinuation
- 1975-12-04 SU SU752195066A patent/SU764608A3/ru active
- 1975-12-04 DD DD189886A patent/DD122963A5/xx unknown
- 1975-12-05 DE DE19752554882 patent/DE2554882A1/de not_active Ceased
- 1975-12-05 CS CS758281A patent/CS191948B2/cs unknown
- 1975-12-05 CH CH1588575A patent/CH618414A5/de not_active IP Right Cessation
- 1975-12-05 HU HUIE724A patent/HU170016B/hu unknown
- 1975-12-05 FR FR7537379A patent/FR2293196A1/fr active Granted
- 1975-12-05 CA CA241,151A patent/CA1064498A/en not_active Expired
- 1975-12-05 AT AT927475A patent/AT347432B/de not_active IP Right Cessation
- 1975-12-05 BE BE162509A patent/BE836353A/xx unknown
- 1975-12-05 ES ES443237A patent/ES443237A1/es not_active Expired
- 1975-12-06 JP JP50145834A patent/JPS51125227A/ja active Pending
-
1977
- 1977-01-31 ES ES455487A patent/ES455487A1/es not_active Expired
- 1977-01-31 ES ES455486A patent/ES455486A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2293196A1 (fr) | 1976-07-02 |
| DK546575A (da) | 1976-06-07 |
| SE7513676L (sv) | 1976-06-08 |
| IL48477A0 (en) | 1976-03-31 |
| IE42454L (en) | 1976-06-06 |
| IL48477A (en) | 1979-09-30 |
| CS191948B2 (en) | 1979-07-31 |
| NL7514070A (nl) | 1976-06-09 |
| ES455486A1 (es) | 1978-01-16 |
| IE42454B1 (en) | 1980-08-13 |
| ZA757089B (en) | 1976-10-27 |
| AR213278A1 (es) | 1979-01-15 |
| PL102292B1 (pl) | 1979-03-31 |
| HU170016B (fi) | 1977-03-28 |
| US4055595A (en) | 1977-10-25 |
| NO753837L (fi) | 1976-06-09 |
| BE836353A (fr) | 1976-06-08 |
| AT347432B (de) | 1978-12-27 |
| PL102241B1 (pl) | 1979-03-31 |
| ATA927475A (de) | 1978-05-15 |
| GB1499508A (en) | 1978-02-01 |
| LU73936A1 (fi) | 1977-02-15 |
| ES443237A1 (es) | 1977-04-16 |
| AU8661975A (en) | 1977-05-19 |
| DE2554882A1 (de) | 1976-06-16 |
| DD122963A5 (de) | 1976-11-12 |
| PL102604B1 (pl) | 1979-04-30 |
| JPS51125227A (en) | 1976-11-01 |
| SU764608A3 (ru) | 1980-09-15 |
| FR2293196B1 (fi) | 1978-07-28 |
| CA1064498A (en) | 1979-10-16 |
| FI753393A (fi) | 1976-06-07 |
| ES455487A1 (es) | 1978-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3219244A1 (de) | Sulfonatderivate, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel | |
| DD283802A5 (de) | Verfahren zur gewinnung von enantiomeren | |
| DE2047658C3 (de) | 2-Styryl- und 2-Phenyläthinylbenzylaminderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| EP0025192B1 (de) | Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel | |
| CH494730A (de) | Verfahren zur Herstellung von Dibenzocyclopentenen | |
| DE2657978C3 (de) | Linksdrehende Enantiomere und Racemate von Trifluormethylthio(und -sulfonyl)cyproheptadinderivaten, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| CH618414A5 (fi) | ||
| CH622769A5 (fi) | ||
| DE2929760C2 (fi) | ||
| CH640513A5 (de) | Optisch aktive phenylalkansaeure-m-phenoxybenzylester. | |
| DE2633931A1 (de) | Pyrazolderivate, deren salze mit saeuren, verfahren zu ihrer herstellung und arzneipraeparate | |
| DE2903094C3 (de) | Naphtyl-1-essigsäurederivate, Verfahren zu deren Herstellung und diese enthaltende Mittel | |
| DE2722657A1 (de) | Essigsaeurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| AT392068B (de) | Optisch aktive oxo-isoindolinylderivate | |
| AT348987B (de) | Verfahren zur herstellung von neuen fluorierten alkansaeurederivaten und von deren additionssalzen | |
| DE2440381A1 (de) | Substituierte phenoxyalkancarbonsaeuren, salze hiervon sowie verfahren zu ihrer herstellung | |
| CH650241A5 (de) | Phenylessigsaeurederivate, ihre herstellung und pharmazeutische praeparate. | |
| DE2934375A1 (de) | Hydroxyessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| DE1668990A1 (de) | Halogensubstituierte p-(p-Alkoxyphenoxy)-phenoxyalkancarbonsaeuren und die entsprechenden Alkylester und Alkancarbonsaeureamide | |
| EP0758648A1 (de) | Substituierte 4H-Pyrane mit einer modulierende Wirkung auf Kaliumkanäle | |
| EP0007347B1 (de) | Lipidsenkende Alkylenglykolderivate und Verfahren zu ihrer Herstellung | |
| CH493456A (de) | Verfahren zur Herstellung von (4-(2-Methylen-alkanoyl)-phenoxy)-alkancarbonsäuren | |
| CH495935A (de) | Verfahren zur Herstellung von Methylen-substituierten Verbindungen | |
| DE1643460C (de) | (3-Trifluormethylphenoxy)-(4-chlorphenyl)-essigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE857501C (de) | Verfahren zur Herstellung von Disulfiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |